Med-X, Inc. (MXRX)

Med-X Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.62	1.37	0.75
Cash & Cash Equivalents	0.62	1.37	0.75
Cash Growth	-	81.63%	-
Receivables	1.08	0.03	0.15
Inventory	0.5	1.02	0.75
Other Current Assets	0	0.24	0.1
Total Current Assets	2.19	2.65	1.76
Property, Plant & Equipment	-	0.09	0.08
Goodwill and Intangibles	-	1.07	1.33
Total Long-Term Assets	-	1.16	1.41
Total Assets	-	3.82	3.17
Accounts Payable	-	0.46	0.49
Current Debt	-	0.26	0.59
Other Current Liabilities	0.91	0	0
Total Current Liabilities	0.91	0.71	1.08
Long-Term Debt	-	0.95	1.16
Total Long-Term Liabilities	-	0.95	1.16
Total Liabilities	-	1.66	2.23
Total Debt	1.16	1.21	1.74
Debt Growth	-	-30.91%	-
Retained Earnings	-	-17.07	-12.16
Shareholders' Equity	1.5	2.15	0.93
Net Cash / Debt	-0.54	0.16	-0.99
Working Capital	1.29	1.94	0.68

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).